scholarly article | Q13442814 |
P2093 | author name string | Kenneth D Bloch | |
Binglan Yu | |||
Warren M Zapol | |||
P2860 | cites work | Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis | Q28278052 |
Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery | Q28344146 | ||
Summary: systemic effects of inhaled nitric oxide | Q30439923 | ||
Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin | Q34133584 | ||
Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. | Q34612107 | ||
Sickle cell disease vasculopathy: a state of nitric oxide resistance | Q34747999 | ||
Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial | Q34948322 | ||
Current status of blood substitute research: towards a new paradigm | Q35110088 | ||
Inhaled NO as a therapeutic agent | Q36003322 | ||
Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions | Q37016302 | ||
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics | Q37048314 | ||
Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injury | Q37077525 | ||
Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat. | Q37100160 | ||
Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds | Q37382837 | ||
Nanobiotechnology for hemoglobin-based blood substitutes | Q37430680 | ||
Muscle cell injury, haemolysis and dark urine in children with falciparum malaria in Papua New Guinea | Q40484288 | ||
Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. | Q45927570 | ||
Inhaled nitric oxide does not reduce systemic vascular resistance in mice | Q46813451 | ||
Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury | Q47351587 | ||
Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin | Q47857012 | ||
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. | Q51711116 | ||
Resuscitation with recombinant hemoglobin rHb2.0 in a rodent model of hemorrhagic shock. | Q51795653 | ||
A clinical safety trial of stroma-free hemoglobin | Q67242625 | ||
Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure | Q73080410 | ||
Blood trauma induced by clinically accepted oxygenators | Q74565712 | ||
Permeability characteristics of hemoglobin derivatives across cultured endothelial cell monolayers | Q77485145 | ||
Pharmacological and physicochemical factors in the pressor effects of conjugated haemoglobin-based oxygen carriers in vivo | Q79721132 | ||
P433 | issue | 3 | |
P304 | page(s) | 103-107 | |
P577 | publication date | 2009-04-01 | |
P1433 | published in | Trends in Cardiovascular Medicine | Q1850265 |
P1476 | title | Hemoglobin-based red blood cell substitutes and nitric oxide | |
P478 | volume | 19 |
Q40082240 | Acute kidney function and morphology following topload administration of recombinant hemoglobin solution. |
Q42371023 | Artificial Blood for Dogs. |
Q47777160 | Difficult to swallow: warm autoimmune hemolytic anemia in a Jehovah's Witness treated with hemoglobin concentrate complicated by achalasia |
Q34194945 | Down selection of polymerized bovine hemoglobins for use as oxygen releasing therapeutics in a guinea pig model |
Q33692944 | Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier |
Q36801603 | Examining and mitigating acellular hemoglobin vasoactivity |
Q35644835 | Hemoglobin βCys93 is essential for cardiovascular function and integrated response to hypoxia |
Q34150422 | Hypervolemic infusion of Lumbricus terrestris erythrocruorin purified by tangential-flow filtration |
Q57025124 | Inhaled Nitric Oxide |
Q37367699 | Inhaled nitric oxide attenuates the adverse effects of transfusing stored syngeneic erythrocytes in mice with endothelial dysfunction after hemorrhagic shock |
Q99406425 | Model-based evaluation of the microhemodynamic effects of PEGylated HBOC molecules in the rat brain cortex: a laser speckle imaging study |
Q37887771 | Nitric oxide: a guardian for vascular grafts? |
Q49926046 | Pulmonary Delivery of Therapeutic and Diagnostic Gases. |
Q37897234 | Systems biology of HBOC-induced vasoconstriction |
Q47305258 | The air we breathe: three vital respiratory gases and the red blood cell: oxygen, nitric oxide, and carbon dioxide |
Q48117391 | Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series |
Search more.